ATOH1 and deafness: In contrast, in a model of aminoglycoside-induced profound deafness, although Atoh1 gene therapy induced the conversion of nonsensory cells in the cochlea into HCs, the resulting HCs failed to mature fully and did not improve hearing in the treated animals (Atkinson et al., 2014).